001     285044
005     20240229162409.0
024 7 _ |a 10.1007/s00066-023-02162-x
|2 doi
024 7 _ |a pmid:37889301
|2 pmid
024 7 _ |a 0179-7158
|2 ISSN
024 7 _ |a 1439-099X
|2 ISSN
024 7 _ |a altmetric:155831219
|2 altmetric
037 _ _ |a DKFZ-2023-02187
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Büttner, Marcel
|b 0
245 _ _ |a Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO).
260 _ _ |a Heidelberg
|c 2024
|b Springer Medizin
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1706170178_5729
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Feb;200(2):151-158
520 _ _ |a Modern digital teaching formats have become increasingly important in recent years, in part due to the COVID-19 pandemic. In January 2021, an online-based webinar series was established by the German Society for Radiation Oncology (DEGRO) and the young DEGRO (yDEGRO) working group. In the monthly 120-minute courses, selected lecturers teach curricular content as preparation for the board certification exam for radiation oncology.The evaluation of the 24 courses between 01.2021 and 12.2022 was performed using a standardized questionnaire with 21 items (recording epidemiological characteristics of the participants, didactic quality, content quality). A Likert scale (1-4) was used in combination with binary and open-ended questions.A combined total of 4200 individuals (1952 in 2021 and 2248 in 2022) registered for the courses, and out of those, 934 participants (455 in 2021 and 479 in 2022) later provided evaluations for the respective courses (36% residents, 35% specialists, 21% medical technicians for radiology [MTR], 8% medical physics experts [MPE]). After 2 years, 74% of the DEGRO Academy curriculum topics were covered by the monthly webinars. The overall rating by participants was positive (mean 2021: 1.33 and 2022: 1.25) and exceeded the curriculum offered at each site for 70% of participants. Case-based learning was identified as a particularly well-rated method.The DEGRO webinar expands the digital teaching opportunities in radiation oncology. The consistently high number of participants confirms the need for high-quality teaching and underlines the advantages of e‑learning methods. Optimization opportunities were identified through reevaluation of feedback from course participants. In its design as a teaching format for a multiprofessional audience, the webinar series could be used as a practice model of online teaching for other disciplines.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Medical education
|2 Other
650 _ 7 |a Online webinar
|2 Other
650 _ 7 |a Radiation oncology
|2 Other
650 _ 7 |a Teaching format
|2 Other
650 _ 7 |a e‑learning
|2 Other
700 1 _ |a Melton, Philip
|b 1
700 1 _ |a Fietkau, Rainer
|b 2
700 1 _ |a Petersen, Cordula
|b 3
700 1 _ |a Krause, Mechthild
|0 P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9
|b 4
|u dkfz
700 1 _ |a Borgmann, Kerstin
|b 5
700 1 _ |a Wolf, Ulrich
|b 6
700 1 _ |a Niyazi, Maximilian
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Christiansen, Hans
|b 8
700 1 _ |a Höller, Ulrike
|b 9
700 1 _ |a Schmitt, Daniela
|b 10
700 1 _ |a Käsmann, Lukas
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Linde, Philipp
|b 12
700 1 _ |a Fleischmann, Daniel
|0 P:(DE-He78)bc38e646ac503a9cfbb96025c129189d
|b 13
700 1 _ |a Ziegler, Sonia
|b 14
700 1 _ |a Bresch, Angelique
|b 15
700 1 _ |a Mäurer, Matthias
|0 0000-0001-9662-3082
|b 16
773 _ _ |a 10.1007/s00066-023-02162-x
|0 PERI:(DE-600)2003907-4
|n 2
|p 151-158
|t Strahlentherapie und Onkologie
|v 200
|y 2024
|x 0179-7158
909 C O |p VDB
|o oai:inrepo02.dkfz.de:285044
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)4be9ccb23f3e472b97743845cd2b3fe9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)bc38e646ac503a9cfbb96025c129189d
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-08-28
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-08-28
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-28
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b STRAHLENTHER ONKOL : 2022
|d 2023-08-28
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-28
920 1 _ |0 I:(DE-He78)DD01-20160331
|k DD01
|l DKTK Koordinierungsstelle Dresden
|x 0
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)DD01-20160331
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21